Assays of antibodies to a C-terminal peptide or the entire β-subunit of human chorionic gonadotropin

Journal of Clinical Laboratory Analysis

Volumn 12, Issue 1, 1998, Pages 60-64

  Cekan, Sten Z ^a,b   Aedo, Ana Rosa ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Contraception; Immunization; Pregnancy; Quantitation; Threshold

Indexed keywords

CHORIONIC GONADOTROPIN ANTIBODY; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ANTIBODY DETECTION; ARTICLE; CARBOXY TERMINAL SEQUENCE; CONTRACEPTION; CROSS REACTION; HUMAN; IMMUNIZATION; NONHUMAN; PREGNANCY; RABBIT;

ANIMALS; ANTIBODIES; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; FEMALE; HUMANS; IMMUNIZATION; PEPTIDE FRAGMENTS; RABBITS;

ORYCTOLAGUS CUNICULUS;

EID: 0031890722     PISSN: 08878013     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2825(1998)12:1<60::AID-JCLA10>3.0.CO;2-M     Document Type: Article

References (14)

1. Hearn JP, Webley GE, Gidley-Baird AA: Chorionic gonadotrophin and embryo-maternal recognition during the peri-implantation period in primates. J Reprod Fen 92:497-509, 1991.
2. Talwar GP, Singh O, Pal R, Chatterjee N, Sahai P, Dhall K, Kaur J, Das SK, Suri S, Buckshee K, Saraya L, Saxena BN: A vaccine that prevents pregnancy in women. Proc Natl Acad Sci 91:8532-8536, 1994.
3. Stevens VC, Powell JE, Lee AC, Griffin D: Antifertility effects of immunization of female baboons with C-terminal peptides of the β-subunit of human chorionic gonadotropin, Fertility Sterility 36:98-105, 1981.
4. Jones WR, Judd SJ, Ing RMY, et al.: Phase I clinical trial of a World Health Organization birth control vaccine. Lancet 1295-1298, 1988.
5. Powell JE, Lee AC, Tregear GW, Niall HD, Stevens VC: Characteristics of antibodies raised to carboxy-terminal peptides of hCG β-subunit. J Reprod Immunol 2:1-13, 1980.
6. Scatchard G: The attractions of proteins for small molecules and ions. Ann NY Acad Sci 51:660-672, 1948.
7. Munson PJ: User's Guide to LIGAND: Data analysis and curve-fitting, for ligand binding experiments. Laboratory of Theoretical and Physical Biology, NIHHD, Bethesda, MD, 1987.
8. Dirnhofer S, Klieber R, De Leeuw R, et al.: Functional and immunological relevance of the COOH-terminal extension of human chorionic gonadotropin: Implications for the WHO birth control vaccine. FASEB 7:1381-1385, 1993.
9. Dirnhofer S, Wick G, Berger P: The suitability of human chorionic gonadotropin (hCG)-based birth-control vaccines. Immunology Today 15:469-474, 1994.
10. Benagiano G: The WHO birth control vaccine. FASEB 8:784-786, 1994.
11. Griffin PD: Birth-control vaccines. Immunology Today 16:502, 1995.
12. Moyle WR, Lin C, Corson RL: Quantitative explanation for increased affinity shown by mixtures of monoclonal antibodies: Importance of a circular complex. Mol Immunol 30:439-452, 1983.
13. Talwar GP: Immuno-contraception. Current Opin Immunol 6:698-704, 1994.
14. Madersbacher S, Klieber R, Mann K, et al.: Free α-subunit, free β-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients. Clin Chem 38:370-376, 1992.